Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mahshid Azimi
Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
Pharmacotherapy
Pharmacology
Related publications
Histone Deacetylase Inhibitors in Multiple Myeloma
Hematology Reports
Hematology
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple Myeloma
Molecular Cancer Therapeutics
Cancer Research
Oncology
New Insights Into the Treatment of Multiple Myeloma With Histone Deacetylase Inhibitors
Current Pharmaceutical Design
Drug Discovery
Pharmacology
Carfilzomib for Relapsed or Refractory Multiple Myeloma
The Lancet Oncology
Oncology
Emerging Role of Carfilzomib in Treatment of Relapsed and Refractory Lymphoid Neoplasms and Multiple Myeloma
Core Evidence
Medicine
Reviews
References
Pharmacology
Bendamustine in Patients With Relapsed or Refractory Multiple Myeloma
European Journal of Medical Research
Medicine
Thioredoxin in Cancer—Role of Histone Deacetylase Inhibitors
Seminars in Cancer Biology
Cancer Research
Histone Deacetylase Inhibitors Valproic Acid and Vorinostat Enhance Trastuzumab-Mediated Antibody-Dependent Cell-Mediated Phagocytosis
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Inhibitors of Histone-Deacetylase
Journal of Applied Biomedicine
Genetics
Molecular Biology
Pharmacology
Biochemistry
Biological Sciences
Toxicology
Medicine
Agricultural
Neuroscience
Pharmaceutics